TJX Stock Pops After Earnings Show Consumers Crave Value
TJX stock is higher Wednesday after the TJ Maxx parent beat Q2 expectations and raised its full-year outlook. Here's what you need to know.


TJX Companies (TJX) stock is trading higher Wednesday after the off-brand retailer beat top- and bottom-line expectations for its fiscal second quarter and raised its full-year outlook.
In the 13 weeks ended August 3, TJX's revenue increased 5.6% year-over-year to $13.5 billion, driven by comparable-store sales growth across all its brands and geographies. This included 5% combined domestic growth at TJ Maxx, Marshalls and Sierra. Its earnings per share (EPS) increased 12.9% from the year-ago period to 96 cents.
"I am extremely pleased with our second-quarter performance. Our comparable store sales increase of 4%, pretax profit margin, and earnings per share all exceeded our plans," said TJX CEO Ernie Herrman in a statement. "Our overall comparable-sales growth was entirely driven by customer transactions, which increased at every division."
From just $107.88 $24.99 for Kiplinger Personal Finance
Be a smarter, better informed investor.

Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The results topped analysts' expectations. Wall Street was anticipating revenue of $13.3 billion and earnings of 92 cents per share, according to Yahoo Finance.
"With our strong second-quarter results, we are raising our full-year guidance for both pretax profit margin and earnings per share," Herrman said, adding that "the third quarter is off to a strong start."
Here's what TJX now expects to accomplish versus its previous forecasts:
Metric | New outlook | Previous outlook |
---|---|---|
Comparable-store sales | Approximately 3% | 2% to 3% |
Pre-tax profit margin | Approximately 11.2% | 11% to 11.1% |
EPS | $4.09 to $4.13 | $4.03 to $4.09 |
For the third quarter, TJX said it anticipates comparable-store sales growth in the range of 2% to 3% and earnings per share in the range of $1.06 to $1.08, which comes up just shy of the $1.10 per share analysts are expecting.
Is TJX stock a buy, sell or hold?
TJX has had a standout year on the charts, up 28% on a total return basis (price change plus dividends). Unsurprisingly, Wall Street is bullish on the consumer discretionary stock.
Of the 25 analysts covering TJX tracked by S&P Global Market Intelligence, 16 have it at Strong, Buy, five call it a Buy, three say it's a Hold and one has it at Sell. This works out to a consensus Buy recommendation and with strong conviction.
Speaking for the bulls is Jefferies analyst Corey Tarlowe, who has a Buy rating and $130 price target on the retail stock. "TJX should benefit from secular migration towards the off-price sector, which should bounce back more quickly and strongly than other retail sectors," Tarlowe writes in a note to clients. "Home and international expansion are unique growth opportunities."
However, not all analysts are bullish on TJX. Financial services firm CFRA Research rates TJX stock a Sell with a $100 price target. The stock is trading at 36 times fiscal 2026 earnings estimates, which is expensive for this top retailer, says CFRA Research analyst Zachary Warring.
CFRA's $100 price target represents a discount of 17% to current levels.
Related Content
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.

Joey Solitro is a freelance financial journalist at Kiplinger with more than a decade of experience. A longtime equity analyst, Joey has covered a range of industries for media outlets including The Motley Fool, Seeking Alpha, Market Realist, and TipRanks. Joey holds a bachelor's degree in business administration.
-
Don't Toss It! Why Your Medicare Annual Notice of Change Matters
If you have Medicare Part D or a Medicare Advantage plan, reviewing your Annual Notice of Change is crucial. It can save you money and ensure you can still see your preferred doctors and hospitals.
-
S&P 500 Hits New High After Oracle Earnings: Stock Market Today
Another down day for Apple held the Dow Jones Industrial Average back, though.
-
S&P 500 Hits New High After Oracle Earnings: Stock Market Today
Another down day for Apple held the Dow Jones Industrial Average back, though.
-
StubHub IPO: Should You Buy STUB Stock?
The highly anticipated StubHub IPO is right on our doorstep, with the online ticket marketplace expected to start trading later this month.
-
What Your Portfolio Says About You – and Your Relationship with Risk
How well do you understand yourself and your risk tolerance? Being able to answer this question will help you become a better investor.
-
Answers to Every Early Retiree's Questions This Year, From a Wealth Adviser
From how to retire in a crazy market to how much to withdraw and how to spend without feeling guilty, a financial pro shares the advice he's given this year.
-
The Risks of Forced DST-to-UPREIT Conversions, From a Real Estate Expert
Some new Delaware statutory trust offerings are forcing investors into 721 UPREIT conversions at the end of the hold period, raising concerns about loss of control, limited liquidity, opaque valuations and unexpected tax liabilities.
-
Stocks Grind Up to New All-Time Highs: Stock Market Today
UnitedHealth stock led the Dow Jones Industrial Average amid increasing signs the labor market has not been well for months.
-
The 'Nothing Ever Happens' Market: How Stocks React (Or Don't) to Geopolitical Events
Geopolitical events – terrorist acts, wars or military intervention – can give stocks a jolt. But that doesn't mean your portfolio will take a long-term hit.
-
I'm a Financial Adviser: You've Built Your Wealth, Now Make Sure Your Family Keeps It
The Great Wealth Transfer is well underway, yet too many families aren't ready. Here's how to bridge the generation gap that could threaten your legacy.